ResearchHealthcare › NVCT
Back to Dashboard

NVCT

Nuvectis Pharma, Inc.
Healthcare · Biotechnology
Market cap $617.6M

Price Chart

Composite ScoreAbove average
56.4Score
FF5
60
MF
PIO
33
QARP
27
CG
93
CV
0
Intrinsic ValueModel estimate

No intrinsic-value estimate for this name yet — the valuation models need fundamentals we don't have.

Factor Profile
FF5PIOQARPMFCVCG

MF has no score for this name — dashed, held at the midpoint.

Where NVCT sits · all 2,442 covered names
NVCT 56.4050100

Ranks 931 of 2,442 — the 61.9th percentile, and 178 of 437 within Healthcare.

Sector Outlook — Healthcare
Pro · locked

Overweight / neutral / underweight call for Healthcare, with conviction, catalysts and risks from our sector deep-research panel.

Upgrade to Pro to unlock sector outlooks →
Analyzing sector peers…

Latest News — NVCT

Options-Implied

The market's own forecast: implied move into earnings, skew, and how today's implied volatility compares with what actually happened the last eight times this name reported.

Create a free account →

The score is free. What changes is the product.

Every number above stays free and needs no account. What we sell is the delta — the day a model changes its reading, the research behind the change, and the book we run on it.

Rating-change alerts

Tell me the day any model changes its reading on NVCT. The score is a snapshot; the change is the signal.

Pre-trade research

The full note behind the number — what the models are reacting to, and what would break the case.

The tracked book

Our own 15-name portfolio, marked daily against the S&P 500 since inception. Every position public.

Peers & sector

NVCT against every name in Healthcare, on every model at once.

Free daily briefing, no card. We’ll tell you when per-ticker rating-change alerts open. Unsubscribe in one click.

Sanctuary Research publishes quantitative investment research and educational content. Nothing here is personalised investment advice, and a model score is not a recommendation to buy or sell. Markets involve risk; do your own due diligence. Scores as of 2026-07-30.